A detailed history of Schonfeld Strategic Advisors LLC transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 17,071 shares of SRTS stock, worth $78,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,071
Holding current value
$78,526
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$5.95 - $8.95 $101,572 - $152,785
17,071 New
17,071 $116,000
Q3 2022

Nov 14, 2022

SELL
$7.64 - $14.97 $18,336 - $35,928
-2,400 Reduced 16.9%
11,800 $147,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $11.37 $29,652 - $47,754
4,200 Added 42.0%
14,200 $109,000
Q1 2022

May 16, 2022

BUY
$6.83 - $11.84 $68,300 - $118,400
10,000 New
10,000 $101,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $76.2M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.